ORTEXORTEX News
Tracking EXLS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EX
Earnings PreviewEXLS

EXLS Options Signal a Shift as Shorts Trim Before the Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 28 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ExlService Holdings reports Q3 results on October 28, and the most striking change in its positioning is not in the short book but in options, where call demand has surged to levels rarely seen over the past year.

The put/call ratio has collapsed to 0.40, against a 20-day average of 3.15. That average was elevated because the PCR spent most of September and early October above 4.5, close to its 52-week peak of 5.01, reflecting heavy put accumulation. Since mid-October, that positioning has unwound sharply. The ratio is now 1.4 standard deviations below its recent mean, the lowest defensive reading in more than a month. Whether that reflects profit-taking on puts ahead of the print, or genuine rotation into calls, the options market is no longer positioned for a sharp drop.

Short sellers have also been retreating. Short interest fell roughly 5% in the session to October 26, and is down about 6% over the past month, bringing it to 6.3% of the free float. That remains a meaningful level, but the direction has clearly turned. The borrow market confirms that bears are not piling in: availability is extremely loose at nearly 4,900% of short interest, meaning the pool of shares available to lend is vastly larger than what is currently borrowed. Cost to borrow, at 0.47%, has nearly doubled over the past week but in absolute terms it is still negligible. The lending market offers no sign of a squeeze.

The Street has been broadly constructive since the July print, when the stock jumped 12.5% in a single session and Baird upgraded to Outperform while lifting its target from $35 to $45. TD Cowen and Needham also raised targets after that result. The consensus price target of $45.13 sits about 10% above Tuesday's close of $40.93, which itself reflects a 17.8% gain over the past month. The bull case rests on AI and analytics expansion across insurance, healthcare and banking. The bear case, articulated most directly by a $40 target with a 16x FY27 earnings multiple, is that margin guidance for 2026 is flat year-on-year and that growth in the key verticals may be decelerating. The stock's trailing PE of 16x and EV/EBITDA of 11x are not stretched multiples for the sector, but they leave little room for a guidance miss.

Insider activity over the past 90 days has been net negative, with around $1.3 million in net open-market sales. Most of those sales came from the company's president under a pre-arranged 10b5-1 plan, which reduces their informational weight. One EVP sale in August, worth $175,500, was made outside any plan. The prior earnings print, on July 29, produced a one-day gain of 12.5% and a five-day follow-through of 10.3%. Before that, on July 30, the print produced a one-day decline of 5.7% and a five-day loss of 3.7%. The reaction has swung sharply between the two most recent reports, which makes the outcome particularly hard to frame from positioning alone.

The October 28 print will test whether the AI and analytics growth narrative can absorb the margin scrutiny the bear case demands, at a price that is already up nearly 18% in a month.

Stocks in this article

See the live data behind this article on ORTEX.

Open EXLS on ORTEX →

How this article was generated

Generated
28 Oct 2026, 04:33
Data as of
28 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.